It was previously reported that EPHA2 re-expression in B6 murine melanoma cells activates a non-proteolytic invasive program that proceeds through the activation of cytoskeleton motility, conferring a plasticity in tumor invasiveness [43]. This evidence concerns the gene EPHA2 and melanoma.